SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddys Laboratories reports 86% fall in Q4 consolidated net profit

12 May 2016 Evaluate

Dr Reddys Laboratories has reported results for the fourth quarter and year ended March 31, 2016.

The company has posted a net loss of Rs 5.7 crore for the quarter ended March 31, 2016 as compared to net profit of Rs 571.4 crore for the same quarter in the previous year. Total income of the company has decreased by 10.71% at Rs 2478.7 crore for quarter under review as compared to Rs 2776 crore for the quarter ended March 31, 2015.

On consolidated basis, the company has posted a fall of 85.62% in its net profit after taxes, minority interest and share of profit of associates  at Rs 74.6 crore for the quarter ended March 31, 2016 as compared to Rs 518.8 crore for the corresponding quarter in the FY15. Total income of the company decreased by 2.47% at Rs 3786.9 crore for quarter under review as compared to Rs 3882.9 crore for the same quarter ended previous year.

For the year ended March 31, 2016, the company has posted a fall of 19.35% in its net profit at Rs 1354.5 crore as compared to Rs 1679.4 crore for the same period in the previous year. However, total income of company increased 2.14% at Rs 10452.5 crore for year under review as compared to Rs 10233.8 crore for the period ended March 31, 2015. 

For the year ended March 31, 2016, on the consolidated basis, the company has posted a fall of 9.77% in its net profit after taxes, minority interest and share of profit of associates at Rs 2001.3 crore as compared to Rs 2217.9 crore for the same period in the previous year. However, total income of company has increased by 4.34% at Rs 15558.2 crore for year under review as compared to Rs 14910.6 crore for the period ended March 31, 2015.

Dr. Reddys Lab Share Price

1293.25 -13.55 (-1.04%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×